🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

8 recruiting trials

for Kidney Transplantation, Cytomegalovirus Infections

A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation NCT06243731n/a25 sites📍 Anderlecht📍 Leuven📍 Tallinn Takeda · Tests: No Intervention Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT) NCT06341543NA1 site📍 Grenoble University Hospital, Grenoble · Tests: Quantiferon CMV (assay that determine the presence of CMV-specific T lymphocytes)., Communication of the result of the … Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients NCT06407232Phase 31 site📍 Madison University of Wisconsin, Madison · Tests: Letermovir Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study NCT07294547NA1 site📍 Taipei National Taiwan University Hospital · Tests: Valacyclovir (Valtrex), Valganciclovir (Valcyte) Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Strategy in Renal Transplant Patients NCT05708508Phase 31 site📍 Rouen University Hospital, Rouen · Tests: ROVALCYTE Efficacy and Safety of Leymovir Versus Valganciclovir in Prevention of Cytomegalovirus Infection and Cytomegalovirus Disease in Chinese Kidney Transplant Recipients NCT07266467Phase 41 site📍 Xi'an First Affiliated Hospital Xi'an Jiaotong University · Tests: Letermovir, Valganciclovir Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections NCT06334497Phase 35 sites📍 Paris📍 Paris📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Letermovir, Valganciclovir, Letermovir placebo Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV) NCT06958796Phase 42 sites📍 Boston📍 Dallas Camille N. Kotton, MD · Tests: Cytomegalovirus Immune Globulin Intravenous (Human) monthly for three months
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy